Es un desastre para el sector. La ley Biden se lo carga directamente y lo del banco, según buysidebio:
The majority of biotechs that have any exposure to SVB to get a lone have cash balance there as a promise.
Issue: SVB from what I heard were super levered long/short UST's and blew up. AKA the biotech's cash that was being super safe invested is gone. Catastrophic potentially.
Parecería que el 50% de las bios tienen cash en ese banco, según él.